To analyze how LDL-C/HDL-C ratio and inflammatory marker CRP are organized in acute myocardial infarction

M. Madan Mohan Rao; R. Salma Mahaboob; Obulesu Gundala

doi:10.53730/ijhs.v6nS9.12517

Authors

M. Madan Mohan Rao Associate Professor in General Medicine, Government Medical College, Kadapa, Andhra Pradesh, India
R. Salma Mahaboob Associate Professor in Biochemistry at RSDKS Government Medical College and Hospital, Ambikapur, Chattisgarh. India
Obulesu Gundala
obulesu100@gmail.com
Associate Professor in Microbiology at RSDKS Government Medical College and Hospital, Ambikapur, Chattisgarh. India

Keywords:

Coronary artery diseases, acute myocardial infarction, LDL-C, HDL-C, CRP, hsCRP

Abstract

There is an increasing incidence of coronary artery disease in India. We therefore need a tool to evaluate the severity and prognosis of this acute myocardial infarction. In acute myocardial infarction, the function of plaque rupture and inflammation has already been identified. Aim: To study the organization of LDL-C/HDL-C ratio and inflammatory marker CRP in acute myocardial infarction. Methods and Material: Patients who have been diagnosed as acute myocardial infarction (ST Elevation Acute myocardial Infarction or Unstable angina/Non ST Elevation Myocardial Infarction) and admitted to ICCU of Government of medical sciences, Kadapa, AP. July 2021 to December 2021, are the subjects. Sample consists of 100 cases of acute myocardial infarction. Case history was taken from the patients, and studied according to proforma. Conclusion: Elevated levels of CRP are independent indicators of adverse effects. When contrast with the LDL / HDL ratio, CRP is used for risk stratification and as a prognostic predictor. These findings suggest that in patients with acute myocardial infarction, raised CRP Levels is significant as compared to LDL/HDL ratio.

Downloads

Download data is not yet available.

References

Bogaty P, Poirier P, Simard S, et al. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 2001; 103(25):3062-8.

Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K et al, Early prognostic usefulness of C reactive protein added to thrombolysis in myocardial infarction risk score in acute myocardial infarction, Am. J. Car, Aug 2005; 96; p 533-537.

Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858

Merta, I. N., & Suderana, I. W. (2020). COVID-19 pandemic handling community social and cultural sector stimulus efforts. International Journal of Social Sciences and Humanities, 4(3), 1–12. https://doi.org/10.29332/ijssh.v4n3.434

Nagy AI, Szabo GY, Sotonyi P, Bagyura ZS, Kovacs AI, Kolev K, Merkely B, Szelid ZS. Correlation of clinical findings and clot ultrastructure in coronary and peripheral arterial thrombi. Eur Heart J 2013;34 (Suppl 1):891–892

Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014;35:2929.

Suleiman M, Aronson D, Reisner SA, Kapeliovich MR, Markiewicz W, Levy Y et al, Admission C reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am Jr of Med; Dec 2003, 115; 9 p 695-701.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Tillett WS, Francis Jr T(1930). Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp med 52: 561-585.

Tomada H, Aoki N, Prognostic value of C reactive protein levels within six hours after the onset of acute myocardial infarction, Am Heart J, Aug 2000;140; p 324- 328

Tracy RP; Inflammation markers and coronary heart disease; Curr Opin Lipidol 1999; 10(5):435-41

Wyss CA, Neidhart M, Altwegg L, Spanaus KS, Yonekawa K, Wischnewsky MB,Corti R, Kucher N, Roffi M, Eberli FR, Amann-Vesti B, Gay S, von Eckardstein A,Luscher TF, Maier W. Cellular actors, Toll-like receptors, and local cytokineprofile in acute coronary syndromes. Eur Heart J 2010;31:1457–1469.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study), Am Heart J, June 1963, 65; p 749-757.

Zwaka TP, Hombach V, Torzewski J. C-Reactive Protein-Mediated Low Density Lipoprotein Uptake by Macrophages; Implications for Atherosclerosis. Circulation 2001; 103:1194-97.